Cutting-edge pathology techniques will demonstrate the true nature of breast cancer during the opening session of a categorical course Friday afternoon. Rare and potentially revolutionary, the new methods look set to challenge radiologists’ understanding of breast cancer and could alter their... More »

The 0.6T Fonar Upright MRI is not in the same class as 3T scanners, but it features capabilities superconducting technologies can't match. High-field imaging is performed with the patient relaxed in a supine position. Upright imaging is conducted while the patient sits, stands, or flexes in a... More »

The cardiovascular community has witnessed historic changes in the way cardiovascular disease is evaluated. Recently, the greatest growth has been in cardiac CT to noninvasively diagnose coronary (Figure 1) and noncoronary cardiac disease (Figure 2). More »

Large-screen photographs of cotton bolls, snakeskin, cacti, and trees saddled with the overgrowth of new limbs often star in provocative lectures about early-stage breast cancer by Dr. Laszlo Tabar, a pioneer in mammography education. More »

Groin pain, whether acute or chronic, is a common clinical presentation that can be caused by a diverse array of disorders involving different anatomic structures. This makes definitive diagnosis difficult for even the most experienced clinician. Imaging can be invaluable in both localizing and... More »

Diagnosing pancreatic disease generally requires many different imaging procedures. Ultrasound and CT are most commonly used to evaluate the pancreatic ducts, parenchyma, and adjacent soft tissues. CT-based assessment of pancreatic pathology has been greatly aided by the advent of multislice... More »

As informatics penetrates deeper into other medical specialties, so do the issues of standardization and integration surrounding PACS and digital imaging. More »

Cetuximab (Erbitux), a chimeric antiepidermal growth factor receptor monoclonal antibody currently used to treat metastatic colorectal cancer, is in clinical development for several other solid tumors. Although cutaneous manifestations are the most common toxicities associated with cetuximab, they... More »

In patients with T1c prostate cancer undergoing radical prostatectomy, a PSA level of 2.6 to 4.0 ng/mL may be associated with more favorable pathology than a score of 4.1 to 6.0 ng/mL More »

As inhibitors of the epidermal growth factor receptor (EGFR) become an increasingly common therapeutic option in cancer, appropriate management of their associated toxicities emerges as a critical part of treatment. Cutaneous manifestations, probably linked to the function of the EGFR in epithelial... More »